Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
FDA Label NDC 62207-828

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Granules India Ltd for the product Guaifenesin And Pseudoephedrine Hcl (NDC 62207-828). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingrediens, purposes, uses, warnings, ask a doctor before use if you have, when using this product, stop use and ask a doctor if, if pregnant or breast-feeding, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingrediens

(in each extended-release tablet)

Guaifenesin USP, 600 mg

Pseudoephedrine HCL USP, 60 mg



Guaifenesin USP, 1200 mg

Pseudoephedrine HCL USP, 120 mg

Purposes

Expectorant

Nasal Decongestant

Uses

• helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

• temporarily relieves nasal congestion due to:

• common cold

• hay fever

• upper respiratory allergies

• temporarily restores freer breathing through the nose

• promotes nasal and/or sinus drainage

• temporarily relieves sinus congestion and pressure

Warnings

Do not use if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask A Doctor Before Use If You Have

• heart disease
• high blood pressure
• thyroid disease
• diabetes
• trouble urinating due to an enlarged prostate gland
• persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema
• cough accompanied by too much phlegm (mucus)

When Using This Product

• do not use more than directed

Stop Use And Ask A Doctor If

• you get nervous, dizzy, or sleepless
• symptoms do not get better within 7 days, come back or occur with a fever, rash, or persistent headache. These could be signs of a serious illness.


If Pregnant Or Breast-Feeding

ask a health professional before use.

Keep Out Of Reach Of Children


 In case of overdose, get medical help or contact a Poison Control Centre right away (1-800 222-1222).

Directions

• do not crush, chew, or break tablet

• take with a full glass of water

• this product can be administered without regard for timing of meals

• adults and children 12 years and older:

For 600mg and 60mg: 2 tablets every 12 hours; not more than 4 tablets in 24 hours

For 1200mg and 120mg: 1 tablet every 12 hours; not more than 2 tablets in 24 hours

• children under 12 years of age: do not use

Other Information

• Tamper evident: Do not use if carton is open or if printed seal on blister is broken or missing.
• store between 20-25°C (68-77°F)


Inactive Ingredients

carbomer homopolymer Type B, cellulose microcrystalline, hypromellose, lake of FD&C yellow 6, magnesium stearate, sodium starch glycolate Type A

Questions Or Comments

Contact 1-877-770-3183 Mon-Fri 8:00 AM EST to 5:00 PM PST.

You may also report side effects to this phone number.

Keep the carton.
It contains important information. See end panel for
expiration date.

Manufactured By:

Granules India Limited

Hyderabad – 500 081, INDIA

MADE IN INDIA

Distributed By:

Granules USA, Inc.

Parsippany, NJ 07054

Principal Display Panel

1200-120-mg-foil (1200 120 mg Foi)

1200-120-mg-foil (1200 120 mg Foi)

1200-120-mg-carton (1200 120 mg Carton)

1200-120-mg-carton (1200 120 mg Carton)

600-60-mg-foil (600 60 mg Foi)

600-60-mg-foil (600 60 mg Foi)

600-60-mg-carton (600 60 mg Carton)

600-60-mg-carton (600 60 mg Carton)

* Please review the disclaimer below.